[Vutrisiran (hereditary transthyretin amyloidosis) - Benefit assessment according to ยง 35a SGB V]

Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen
Record ID 32018004361
Original Title: Vutrisiran (hereditaere Transthyretin-Amyloidose mit Polyneuropathie)
Project Status: Completed
Year Published: 2023
English language abstract: There is no English language summary available
Publication Type: Full HTA
Country: Germany
MeSH Terms
  • Amyloid Neuropathies, Familial
  • Amyloidosis, Familial
  • Amyloid Neuropathies
  • Polyneuropathies
  • RNA, Small Interfering
  • Vutrisiran
  • Amyloid Neuropathies
  • Benefit Assessment
  • NCT03759379
Organisation Name: Institute for Quality and Efficiency in Health Care (IQWiG)
Contact Address: IQWiG, Im Mediapark, 8, DE-50670 Cologne, GERMANY, Tel: +49(0)221-35685, Fax: +49(0)221-356851
Contact Email: berichte@iqwig.de
Copyright: Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.